Body-on-a chip: Using microfluidic systems to predict human responses to drugs

Michael L. Shuler, Mandy B. Esch

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Using an in vitro platform technology that combines microfabricated devices with cell culture, we seek to understand the response of the human body to pharmaceuticals and combinations of pharmaceuticals. Computer models of the human body guide the design of in vitro systems we call micro cell culture analogs (μCCAs) or "body-on-a-chip" devices. A μCCA device is a physical representation of a physiologically based pharmacokinetic (PBPK) model and contains mammalian cells cultured in interconnected microchambers to represent key organs linked through a circulatory system. μCCAs can provide inexpensive means for realistic, accurate, and rapid-throughput toxicological studies that do not require experimenting with animals and reveal toxic effects that can result from interactions between organs. As the natural length scale in biological systems is on the order of 10-100 μm, operating on the microscale allows us to mimic physiological relationships more accurately. We summarize proof-of-concept experiments using mixtures of drugs to treat multidrug-resistant (MDR) cancer and colon cancer. We discuss the extension of the μCCA concept to systems that connect barrier tissues with systemic circulation. Examples with models of the gastro - sintestinal (GI) tract are provided.

Original languageEnglish (US)
Pages (from-to)1635-1645
Number of pages11
JournalPure and Applied Chemistry
Issue number8
StatePublished - 2010


  • Barrier tissues
  • Gastrointestinal tract
  • High-throughput screening
  • Micro cell culture analogs
  • Microfluidic cell culture model

ASJC Scopus subject areas

  • General Chemistry
  • General Chemical Engineering


Dive into the research topics of 'Body-on-a chip: Using microfluidic systems to predict human responses to drugs'. Together they form a unique fingerprint.

Cite this